riluzole has been researched along with Decerebrate Posturing in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| St-John, WM | 2 |
| Waki, H | 1 |
| Dutschmann, M | 1 |
| Paton, JF | 1 |
2 other studies available for riluzole and Decerebrate Posturing
| Article | Year |
|---|---|
Maintenance of eupnea of in situ and in vivo rats following riluzole: a blocker of persistent sodium channels.
Topics: Animals; Carbon Dioxide; Decerebrate State; Electromyography; Hypercapnia; Hypoxia; Injections, Intr | 2007 |
Eupnea of in situ rats persists following blockers of in vitro pacemaker burster activities.
Topics: Action Potentials; Animals; Decerebrate State; Excitatory Amino Acid Antagonists; Flufenamic Acid; I | 2008 |